medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2014-3-10-13medsovet-519Research ArticleКОНСУЛЬТАЦИИ ЮРИСТАLEGAL ADVICEРоль мукорегуляторов в лечении острого синуситаRole of mucoregulators in the treatment of acute sinusitisКрюковА. И.KryukovA. I.noemail@neicon.ruТуровскийА. Б.TurovskiyA. B.noemail@neicon.ruКарюкЮ. А.KaryukY. A.noemail@neicon.ruКондрашинаВ. В.KondrashinaV. V.noemail@neicon.ruГБУЗ «Московский научно-практический центр оториноларингологии им. Л.И. Свержевского» Департамента здравоохранения г. МосквыРоссияMoscow Otorhinolaryngology Research and Practical Centre named after L.I. SverzhevskiyRussian Federation201430122014031013Copyright © Крюков А.И., Туровский А.Б., Карюк Ю.А., Кондрашина В.В., 20142014Крюков А.И., Туровский А.Б., Карюк Ю.А., Кондрашина В.В.Kryukov A.I., Turovskiy A.B., Karyuk Y.A., Kondrashina V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/519

The article tells about positive results of the study to evaluate the effect of GeloMyrtol®forte on mucociliary clearance, efficacy and safety in the treatment of acute catarrhal and purulent sinusitis.

острый синуситмукоцилиарный клиренсмукорегуляторыфитопрепаратыГелоМиртол® фортеacute sinusitismucociliary clearancemucoregulatorsherbal medicinesGeloMyrtol® forteReferencesDorow P, Weiss T, Felix R, Schmutzler H. Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease. Arzneimittelforschung, 1987, 37 (12): 1378-1381.Dorow P, Weiss T, Felix R, Schmutzler H. Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease. Arzneimittelforschung, 1987, 37 (12): 1378-1381.Behrbohm H, Kaschke O, Sydow K. The influence of a secretolytic drug on mucociliary clearance of the maxillary sinus. J Rhinol, 1997, 4 (1): 29-33.Behrbohm H, Kaschke O, Sydow K. The influence of a secretolytic drug on mucociliary clearance of the maxillary sinus. J Rhinol, 1997, 4 (1): 29-33.Roos U, Wulkow R, Wortha HP et al. Freie Radikale in Pathogenese und Therapie von entz$ndlichen Erkrankungen des Bronchialsystems, in: Meister R, EntzЯndliche Erkrankungen des Bronchialsystems, Springer Verlag, 1. Auflage 2000, Seiten 1-25.Roos U, Wulkow R, Wortha HP et al. Freie Radikale in Pathogenese und Therapie von entz$ndlichen Erkrankungen des Bronchialsystems, in: Meister R, EntzЯndliche Erkrankungen des Bronchialsystems, Springer Verlag, 1. Auflage 2000, Seiten 1-25.Beuscher N, Kietzmann M, Bien E, Champeroux P. Interference of Myrtol standardised with inflammatory and allergic mediators. Arzneim-Forsch. Drug Res 1998; 48 (II), 985-989 et al. A randomised, multi-centered, placebo controlled phase III double blinded study with parallel group comparison to investigate the efficacy of Myrtol standardized capsules (4x300 mg oral daily) for patients with acute sinusitis. 92/334. Myrtol standardisiert Dokumentation, 1994.Beuscher N, Kietzmann M, Bien E, Champeroux P. Interference of Myrtol standardised with inflammatory and allergic mediators. Arzneim-Forsch. Drug Res 1998; 48 (II), 985-989 et al. A randomised, multi-centered, placebo controlled phase III double blinded study with parallel group comparison to investigate the efficacy of Myrtol standardized capsules (4x300 mg oral daily) for patients with acute sinusitis. 92/334. Myrtol standardisiert Dokumentation, 1994.Hippeli S et al. Freie Radikale in Pathogenese und Therapie von entzЯndlichen Erkrankungen des Bronchialsystems, in: Meister R, EntzЯndliche Erkrankungen des Bronchialsystems, Springer Verlag, 1. Auflage 2000, Seiten 1-25.Hippeli S et al. Freie Radikale in Pathogenese und Therapie von entzЯndlichen Erkrankungen des Bronchialsystems, in: Meister R, EntzЯndliche Erkrankungen des Bronchialsystems, Springer Verlag, 1. Auflage 2000, Seiten 1-25.Christoph F, Kaulfers P-M, Stahl-Biskup E. In vitro evaluation of the antibacterial activity of beta-triketones admixed to Melaleuca oils. Planta Med 2001, 67: 768-771.Christoph F, Kaulfers P-M, Stahl-Biskup E. In vitro evaluation of the antibacterial activity of beta-triketones admixed to Melaleuca oils. Planta Med 2001, 67: 768-771.

The authors declare that there are no conflicts of interest present.